GILD posts strong phase III results for Trodelvy plus Keytruda, cutting TNBC progression risk by 35% compared with standard ...

The first-in-class antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) demonstrated promising efficacy and high response ...

US-based pharmaceutical company Johnson & Johnson has reported data from a Phase I trial of its bispecific antibody, ...

Reducing the copies of one gene in the bubonic plague bacterium, Yersinia pestis, made it less deadly but potentially more ...

The first-in-class antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) demonstrated promising efficacy and high response ...

There has been a noticeable increase in the popularity of glutathione treatments for skin lightening in India. While exact ...

The sisters of a man who survived two overdoses from drugs allegedly supplied by Ed Buck, but who died of a drug overdose before his case against the former Democratic donor could get to trial, ...

A small genetic change makes the bacterium that caused the plague less fatal but possibly more transmissible, allowing for ...

CHICAGO -- Adjuvant cemiplimab (Libtayo) significantly improved disease-free survival (DFS) compared with placebo in patients ...

The ASCENT-03 trial is a phase 3 study assessing the efficacy and safety of sacituzumab govitecan compared with physician’s choice of treatment in patients with previously untreated, locally advanced, ...

Nivolumab plus ipilimumab showed activity in mCRPC, and while adding SBRT was safe, it did not boost efficacy in the CheckPRO trial.

Former MP for South Tongu, Hon. Kobena Mensah Woyome Donates 5,000 Giving Sets to Combat Diarrhea and Vomit Outbreak ...